Bavarian Nordic
Clinical trials sponsored by Bavarian Nordic, explained in plain language.
-
First major trial tests mpox vaccine in young children
⭐️ VACCINE ⭐️ OngoingThis study is testing a vaccine called MVA-BN to see if it is safe and creates a strong immune response in children aged 2 to 12 years old, compared to adults. The goal is to prevent infections from mpox (monkeypox), smallpox, and related viruses. All participants receive two sho…
Phase: PHASE2 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 06:56 UTC
-
Scientists test shot to block deadly mosquito viruses
⭐️ VACCINE ⭐️ OngoingThis study is testing a new vaccine designed to protect adults at high risk from serious brain infections caused by specific mosquito-borne viruses. Researchers are giving the vaccine to 411 healthy volunteers to find the best dose and schedule, and to check how safe it is and if…
Phase: PHASE2 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:12 UTC